About MEDICSKIN Company

Our holding company Medicskin Holdings Limited (stock code: 8307.HK) was listed on the Hong Kong Stock Exchange Limited GEM in 2014. We are a medical skincare group operating two Medicskin centers in Hong Kong that focus mainly on skin treatment. We provide our customers with skin care services aimed at treating a variety of skin problems (including but not limited to) acne, spots, rosacea, dermatitis, eczema, and warts, as well as improving appearance through (including) skin rejuvenation, facial contouring and body contouring treatments, acne scars and enlarged pores, remove unwanted moles, and remove hair. Our scope of services includes: consulting services We diagnose or recommend skin care products or treatments to customers based on their specific needs, requirements, and skin conditions. Treatment services All treatment devices used to treat our clients are assessed and assessed by our team based on certain selection criteria, including whether these devices are evidence-based and/or supported by independent medical journals and/or approved by national government agencies, such as FDA/MFDS/CE/KFDA, to ensure that they are safe and reliable. Precise preventive care We partner with biotech diagnostic companies to provide customers with a range of genetic tests, including genetic risk assessments, accurate cancer testing, ct-DNA early cancer screening, women's health testing, beauty and allergy testing, and comprehensive health screening services. Our goal is to help our customers prevent diseases, help detect specific diseases early, and maintain good health.